RecruitingNCT04431479

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Studying Cryptogenic organizing pneumonia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fred Hutchinson Cancer Center
Principal Investigator: Stephanie J. Lee
Fred Hutch/University of Washington Cancer Consortium
Intervention: Biospecimen Collection(procedure)
Enrollment: 300 enrolled
Eligibility: 18 years · All sexes
Timeline: 2020 – 2026

Study locations (10)

University of Florida, Gainesville, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Dana-Farber Harvard Cancer Center, Boston, Massachusetts, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Vancouver General Hospital/BC Cancer, Vancouver, British Columbia, Canada

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04431479 on ClinicalTrials.gov

Other trials for Cryptogenic organizing pneumonia

Additional recruiting or active studies for the same condition.

See all trials for Cryptogenic organizing pneumonia →

← Back to all trials